S. Snapinn, M. Chen, Q. Jiang, and T. Koutsoukos. Pharmaceutical statistics, 5 (4):
273-81(2006)7401<m:linebreak></m:linebreak>LR: 20071115; JID: 101201192; ppublish;<m:linebreak></m:linebreak>Mesures de contrast; RCT.
P. Vavken, K. Heinrich, C. Koppelhuber, S. Rois, and R. Dorotka. Clinical orthopaedics and related research, 467 (12):
3334-9(December 2009)5892<m:linebreak></m:linebreak>LR: 20101202; JID: 0075674; OID: NLM: PMC2772925; 2008/10/17 received; 2009/03/16 accepted; 2009/03/31 aheadofprint; ppublish; Interessant Figura 1 de la relació entre significació estadística i mida de l'efecte<m:linebreak></m:linebreak>Límits de confiança.
H. Brønnum-Hansen. Journal of epidemiology and community health, 53 (5):
300-5(May 1999)4322<m:linebreak></m:linebreak>LR: 20061115; PUBM: Print; JID: 7909766; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
E. Moodie, and D. Stephens. International journal of public health, 56 (1):
117-9(February 2011)6250<m:linebreak></m:linebreak>GR: Canadian Institutes of Health Research/Canada; JID: 101304551; 2010/05/07 received; 2010/09/12 accepted; 2010/08/01 revised; 2010/10/08 aheadofprint; ppublish;<m:linebreak></m:linebreak>Propensity score; Marginal structural models; Introductori.
A. Stang, C. Poole, and O. Kuss. European journal of epidemiology, 25 (4):
225-30(April 2010)5552<m:linebreak></m:linebreak>M3: 10.1007/s10654-010-9440-x;<m:linebreak></m:linebreak>Significació estadística.
H. Kim. Clinical cancer research : an official journal of the American Association for Cancer Research, 13 (2 Pt 1):
559-65(January 2007)4698<m:linebreak></m:linebreak>LR: 20071203; GR: AI 029530/AI/NIAID NIH HHS/United States; GR: HL 070149/HL/NHLBI NIH HHS/United States; JID: 9502500; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks.